Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 43, 2011 - Issue 1
Submit an article Journal homepage
104
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Infection disclosure in the injecting dyads of Hungarian and Lithuanian injecting drug users who self-reported being infected with hepatitis C virus or human immunodeficiency virus

V. Anna Gyarmathy European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USACorrespondence[email protected]
,
Alan Neaigus Mailman School of Public Health, Columbia University, New York, NY, USA
,
Nan Li Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
,
Eszter Ujhelyi Szent László Hospital, Budapest, Hungary
,
Irma Caplinskiene Centre for Communicable Diseases and AIDS, Vilnius, Lithuania; M. Romeris University, Social Policy Faculty, Vilnius, Lithuania
,
Saulius Caplinskas Centre for Communicable Diseases and AIDS, Vilnius, Lithuania; M. Romeris University, Social Policy Faculty, Vilnius, Lithuania
&
Carl A. Latkin Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
 show all
Pages 32-42 | Received 16 Feb 2010, Accepted 01 Aug 2010, Published online: 15 Sep 2010

References

  • Mayfield Arnold E, Rice E, Flannery D, Rotheram-Borus MJ. HIV disclosure among adults living with HIV. AIDS Care 2008;20:80–92.
  • Latkin CA, Knowlton AR, Forman VL, Hoover DR, Schroeder JR, Hachey M, Celentano DD. Injection drug users’ disclosure of HIV seropositive status to network members. AIDS Behav 2001;5:297–305.
  • Parsons JT, Missildine W, Van Ora J, Purcell DW, Gómez CA. Seropositive Urban Drug Injectors Study. HIV serostatus disclosure to sexual partners among HIV-positive injection drug users. AIDS Patient Care STDS 2004;18:457–69.
  • Kwiatkowski CF, Fortuin Corsi K, Booth RE. The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users. Addiction 2002;97:1289–94.
  • Ompad DC, Fuller CM, Vlahov D, Thomas D, Strathdee SA. Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland. Clin Infect Dis 2002;35:783–8.
  • Gyarmathy VA, Neaigus A, Mitchell MM, Ujhelyi E. The association of syringe type and syringe cleaning with HCV infection among IDUs in Budapest, Hungary. Drug Alcohol Depend 2009;100:240–7.
  • De P, Cox J, Boivin JF, Platt RW, Jolly AM, Alexander PE. HIV and HCV discordant injecting partners and their association to drug equipment sharing. Scand J Infect Dis 2009;41:206–14.
  • Neaigus A. The network approach and interventions to prevent HIV among injection drug users. Public Health Rep 1998;113:140–50.
  • Gyarmathy VA, Li N, Tobin KE, Hoffman IF, Sokolov N, Levchenko J, . Injecting equipment sharing in Russian drug injecting dyads. AIDS Behav 2010;14:141–51.
  • Valente TW, Vlahov D. Selective risk taking among needle exchange participants: implications for supplemental interventions. Am J Public Health 2001;91:406–11.
  • Granovetter M. The strength of weak ties: a network theory revisited. Sociol Theor 1983;1:201–33.
  • Elford J, Ibrahim F, Bukutu C, Anderson J. Disclosure of HIV status: the role of ethnicity among people living with HIV in London. J Acquir Immune Defic Syndr 2008;47:514–21.
  • Wikipedia. Hungary. Available at: http://en.wikipedia.org/wiki/Hungary (accessed 20 November 2009).
  • Wikipedia. Lithuania. Available at: http://en.wikipedia.org/wiki/Lithuania (accessed 20 November 2009).
  • European Monitoring Centre for Drugs and Drug Addiction. Statistical Bulletin 2008. Available at: http://www.emcdda.europa.eu/stats08 (accessed 3 September 2010).
  • Gossop M, Griffiths P, Powis B, Strang J. Severity of dependence and route of administration of heroin, cocaine and amphetamines. Br J Addict 1992;87:1527–36.
  • Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13–22.
  • Schlumberger MG, Desenclos JC, Papaevangelou G, Richardson SC, Ancelle-Park R. Knowledge of HIV serostatus and preventive behaviour among European injecting drug users: second study. European Community Study Group on HIV in Injecting Drug Users. Eur J Epidemiol 1999;15:207–15.
  • Des Jarlais DC, Perlis T, Arasteh K, Hagan H, Milliken J, Braine N, . ‘Informed altruism’ and ‘partner restriction’ in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990–2001. J Acquir Immune Defic Syndr 2004;35:158–66.
  • Desenclos JC, Papaevangelou G, Ancelle-Park R. Knowledge of HIV serostatus and preventive behaviour among European injecting drug users. The European Community Study Group on HIV in Injecting Drug Users. AIDS 1993;7:1371–7.
  • Vidal-Trécan G, Coste J, Varescon-Pousson I, Christoforov B, Boissonnas A. HCV status knowledge and risk behaviours amongst intravenous drug users. Eur J Epidemiol 2000;16: 439–45.
  • Golub ET, Strathdee SA, Bailey SL, Hagan H, Latka MH, Hudson SM, . Distributive syringe sharing among young adult injection drug users in five U.S. cities. Drug Alcohol Depend 2007;91(Suppl 1):S30–8.
  • Rhodes T, Davis M, Judd A. Hepatitis C and its risk management among drug injectors in London: renewing harm reduction in the context of uncertainty. Addiction 2004;99:621–33.
  • Gyarmathy VA, Neaigus A, Ujhelyi E, Szabó T, Rácz J. Strong HIV and hepatitis disclosure norms and frequent risk behaviors among Hungarian drug injectors. Drug Alcohol Depend 2006;82:S65–9.
  • Noden BH, Gomes A, Ferreira A. Influence of religious affiliation and education on HIV knowledge and HIV-related sexual behaviors among unmarried youth in rural central Mozambique. AIDS Care 2010;1–10.
  • Paterson BL, Backmund M, Hirsch G, Yim C. The depiction of stigmatization in research about hepatitis C. Int J Drug Policy 2007;18:364–73.
  • Rácz J, Gyarmathy VA, Neaigus A, Ujhelyi E. Injecting equipment sharing and perception of HIV and hepatitis risk among injecting drug users in Budapest. AIDS Care 2007;19: 59–66.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.